Clinical Trials Browser

Phase 2/3 × Anatomic Stage III Breast Cancer AJCC v8 × 90 days × Clear all

NCT04715958 2026-04-06

SHAPE Neoadjuvant Chemotherapy Response

Phase 2/3 Recruiting

Anatomic Stage III Breast Cancer AJCC v8